Roivant Sciences Statistics
Total Valuation
ROIV has a market cap or net worth of $25.68 billion. The enterprise value is $21.54 billion.
| Market Cap | 25.68B |
| Enterprise Value | 21.54B |
Important Dates
The next estimated earnings date is Monday, August 10, 2026, before market open.
| Earnings Date | Aug 10, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ROIV has 719.27 million shares outstanding. The number of shares has decreased by -4.35% in one year.
| Current Share Class | 719.27M |
| Shares Outstanding | 719.27M |
| Shares Change (YoY) | -4.35% |
| Shares Change (QoQ) | +16.56% |
| Owned by Insiders (%) | 24.11% |
| Owned by Institutions (%) | 75.04% |
| Float | 545.57M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3,114.81 |
| Forward PS | 340.34 |
| PB Ratio | 5.53 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2,608.22 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 18.37, with a Debt / Equity ratio of 0.02.
| Current Ratio | 18.37 |
| Quick Ratio | 18.00 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -7.59% and return on invested capital (ROIC) is -154.09%.
| Return on Equity (ROE) | -7.59% |
| Return on Assets (ROA) | -14.35% |
| Return on Invested Capital (ROIC) | -154.09% |
| Return on Capital Employed (ROCE) | -23.58% |
| Weighted Average Cost of Capital (WACC) | 10.46% |
| Revenue Per Employee | $11,456 |
| Profits Per Employee | -$415,771 |
| Employee Count | 721 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ROIV has paid $133.33 million in taxes.
| Income Tax | 133.33M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +211.77% in the last 52 weeks. The beta is 1.14, so ROIV's price volatility has been higher than the market average.
| Beta (5Y) | 1.14 |
| 52-Week Price Change | +211.77% |
| 50-Day Moving Average | 29.78 |
| 200-Day Moving Average | 24.27 |
| Relative Strength Index (RSI) | 77.05 |
| Average Volume (20 Days) | 5,938,750 |
Short Selling Information
The latest short interest is 33.24 million, so 4.62% of the outstanding shares have been sold short.
| Short Interest | 33.24M |
| Short Previous Month | 36.23M |
| Short % of Shares Out | 4.62% |
| Short % of Float | 6.09% |
| Short Ratio (days to cover) | 5.12 |
Income Statement
In the last 12 months, ROIV had revenue of $8.26 million and -$299.77 million in losses. Loss per share was -$0.54.
| Revenue | 8.26M |
| Gross Profit | -673.94M |
| Operating Income | -1.28B |
| Pretax Income | -264.58M |
| Net Income | -299.77M |
| EBITDA | -1.28B |
| EBIT | -1.28B |
| Loss Per Share | -$0.54 |
Balance Sheet
The company has $4.29 billion in cash and $107.44 million in debt, with a net cash position of $4.18 billion or $5.82 per share.
| Cash & Cash Equivalents | 4.29B |
| Total Debt | 107.44M |
| Net Cash | 4.18B |
| Net Cash Per Share | $5.82 |
| Equity (Book Value) | 5.29B |
| Book Value Per Share | 6.28 |
| Working Capital | 4.89B |
Cash Flow
In the last 12 months, operating cash flow was -$750.35 million and capital expenditures -$8.21 million, giving a free cash flow of -$758.56 million.
| Operating Cash Flow | -750.35M |
| Capital Expenditures | -8.21M |
| Depreciation & Amortization | 3.35M |
| Net Borrowing | n/a |
| Free Cash Flow | -758.56M |
| FCF Per Share | -$1.05 |
Margins
| Gross Margin | n/a |
| Operating Margin | -15,495.19% |
| Pretax Margin | -3,203.12% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ROIV does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.35% |
| Shareholder Yield | 4.35% |
| Earnings Yield | -1.17% |
| FCF Yield | -2.95% |
Analyst Forecast
The average price target for ROIV is $39.04, which is 9.36% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $39.04 |
| Price Target Difference | 9.36% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (3Y) | 499.47% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ROIV has an Altman Z-Score of 17.38.
| Altman Z-Score | 17.38 |
| Piotroski F-Score | n/a |